Daniel Compagno
Daniel Compagno
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
DJ Laderach, LD Gentilini, L Giribaldi, VC Delgado, L Nugnes, DO Croci, ...
Cancer research 73 (1), 86-96, 2013
Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem‐repeat” lectin galectin‐8
VMC Delgado, LG Nugnes, LL Colombo, MF Troncoso, MM Fernández, ...
The FASEB Journal 25 (1), 242-254, 2011
RGS16 is a negative regulator of SDF-1–CXCR4 signaling in megakaryocytes
M Berthebaud, C Riviere, P Jarrier, A Foudi, Y Zhang, D Compagno, ...
Blood 106 (9), 2962-2968, 2005
RNA interference shows critical requirement for NF-κB p50 in the production of IL-12 by human dendritic cells
D Laderach, D Compagno, O Danos, W Vainchenker, A Galy
The Journal of Immunology 171 (4), 1750-1757, 2003
Galectin‐1 triggers epithelial‐mesenchymal transition in human hepatocellular carcinoma cells
ML Bacigalupo, M Manzi, MV Espelt, LD Gentilini, D Compagno, ...
Journal of cellular physiology 230 (6), 1298-1309, 2015
Galectin-8: a matricellular lectin with key roles in angiogenesis
MF Troncoso, F Ferragut, ML Bacigalupo, VM Cárdenas Delgado, ...
Glycobiology 24 (10), 907-914, 2014
SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
D Compagno, C Merle, A Morin, C Gilbert, JRR Mathieu, A Bozec, ...
PLoS One 2 (10), e1006, 2007
Galectins: major signaling modulators inside and outside the cell
D Compagno, FM Jaworski, L Gentilini, G Contrufo, IG Pérez, MT Elola, ...
Current molecular medicine 14 (5), 630-651, 2014
Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings
DJ Laderach, D Compagno, MA Toscano, DO Croci, S Dergan‐Dylon, ...
Iubmb Life 62 (1), 1-13, 2010
A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells
A Olivier, L Jeanson-Leh, G Bouma, D Compagno, J Blondeau, K Seye, ...
Molecular Therapy 13 (4), 729-737, 2006
Glycans and galectins in prostate cancer biology, angiogenesis and metastasis
D Compagno, LD Gentilini, FM Jaworski, IG Pérez, G Contrufo, ...
Glycobiology 24 (10), 899-906, 2014
Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors
MT Elola, F Ferragut, VM Cardenas Delgado, LG Nugnes, L Gentilini, ...
F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de …, 2014
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer
LD Gentilini, FM Jaworski, C Tiraboschi, IG Pérez, ML Kotler, ...
Oncotarget 8 (27), 44654, 2017
Galectins as checkpoints of the immune system in cancers, their clinical relevance, and implication in clinical trials
D Compagno, C Tiraboschi, JD Garcia, Y Rondón, E Corapi, C Velazquez, ...
Biomolecules 10 (5), 750, 2020
Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin
D Compagno, JN Lampe, C Bourget, IV Kutyavin, L Yurchenko, ...
Journal of Biological Chemistry 274 (12), 8191-8198, 1999
Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer
A Chauchereau, N Al Nakouzi, C Gaudin, S Le Moulec, D Compagno, ...
Experimental cell research 317 (3), 262-275, 2011
Dok-4 is a novel negative regulator of T cell activation
A Gérard, M Ghiotto, C Fos, G Guittard, D Compagno, A Galy, S Lemay, ...
The Journal of Immunology 182 (12), 7681-7689, 2009
In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development
FM Jaworski, LD Gentilini, G Gueron, RP Meiss, EG Ortiz, PM Berguer, ...
Clinical Cancer Research 23 (17), 5135-5148, 2017
Endogenous galectin-1 in T lymphocytes regulates anti-prostate cancer immunity
E Corapi, G Carrizo, D Compagno, D Laderach
Frontiers in immunology 9, 2190, 2018
Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers
DJ Laderach, L Gentilini, FM Jaworski, D Compagno
Prostate cancer 2013 (1), 519436, 2013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20